Trial Details
COMPLETEDBasic Information
| Clinical ID | c982 |
|---|---|
| Identifier | NCT02888379 |
| Trial Title | Phase 2a Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: TOP1288|DRUG: Placebo (for TOP1288) |
Participant Information
| Sponsor | Topivert Pharma Ltd |
|---|---|
| City | Plovdiv |
| Country/Region | Bulgaria |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-09-16 |
|---|---|
| Primary Completion Date | 2017-06-28 |
| Completion Date | 2017-06-28 |